Histone methylation analysis and pathway predictions in chickens after MDV infection

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Luo, Juan ^a   Mitra, Apratim ^a   Tian, Fei ^a   Chang, Shuang ^b,d   Zhang, Huanmin ^b   Cui, Kairong ^c   Yu, Ying ^a,e   Zhao, Keji ^c   Song, Jiuzhou ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; HISTONE H3; LYSINE; MESSENGER RNA; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CHICKEN; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCATION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC LINE; GENETIC SUSCEPTIBILITY; HISTONE METHYLATION; IMMUNE RESPONSE; MARDIVIRUS; MAREK DISEASE; MOLECULAR DYNAMICS; NONHUMAN; SEQUENCE ANALYSIS;

ANIMALS; CHICKENS; CHROMATIN IMMUNOPRECIPITATION; DISEASE RESISTANCE; DISEASE SUSCEPTIBILITY; GENOMICS; HISTONES; LYSINE; MAREK DISEASE; METHYLATION; MICRORNAS; POULTRY DISEASES; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY; SPLEEN; TRANSCRIPTOME;

EID: 84864861877     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041849     Document Type: Article

References (83)

1. Fred Davidson VN, editor. Marek's disease: An evolving problem. London: Elsevier Academic Press.
2. Buckmaster AE, Scott SD, Sanderson MJ, Boursnell MEG, Ross NLJ, et al. ((1988)) Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys: implications for herpesvirus classification. Journal of General Virology 69:: 2033.
3. Tulman E, Afonso C, Lu Z, Zsak L, Rock D, et al. ((2000)) The genome of a very virulent Marek's disease virus. Journal of Virology 74:: 7980.
4. Burgess SC, Young JR, Baaten BJ, Hunt L, Ross LN, et al. ((2004)) Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30). Proc Natl Acad Sci U S A 101:: 13879--13884.
5. Calnek BW, ((2001)) Pathogenesis of Marek's disease virus infection. Curr Top Microbiol Immunol 255:: 25--55.
6. Asmundson V, Biely J, ((1932)) Inheritance of resistance to fowl paralysis (Neurolymphomatosis gallinarum). I. Differences in susceptibility Canad Jour Res 6:: 171--176.
7. Hutt F, Cole R, ((1947)) Genetic Control of Lymphomatosis in the Fowl. Science (New York, NY) 106:: 379.
8. Cole RK, ((1968)) Studies on genetic resistance to Marek's disease. Avian Diseases 12:: 9--28.
9. Stone HA (1975) Use of highly inbred chickens in research: Agricultural Research Service, US Dept. of Agriculture.
10. Stone HA (1975) United States. Agricultural Research Service (1975) Use of highly inbred chickens in research. Washington: Agricultural Research Service U.S. Dept. of Agriculture. 21.
11. Fredericksen TL, Longenecker BM, Pazderka F, Gilmour DG, Ruth RF, ((1977)) A T-cell antigen system of chickens: Ly-4 and Marek's disease. Immunogenetics 5:: 535--552.
12. Gilmour DG, Brand A, Donnelly N, Stone HA, ((1976)) Bu-1 andTh-1, two loci determining surface antigens of B or T lymphocytes in the chicken. Immunogenetics 3:: 549--563.
13. Kaiser P, Underwood G, Davison F, ((2003)) Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease. J Virol 77:: 762--768.
14. Kuhnlein U, Ni L, Weigend S, Gavora JS, Fairfull W, et al. ((1997)) DNA polymorphisms in the chicken growth hormone gene: response to selection for disease resistance and association with egg production. Anim Genet 28:: 116--123.
15. Liu HC, Cheng HH, Tirunagaru V, Sofer L, Burnside J, ((2001)) A strategy to identify positional candidate genes conferring Marek's disease resistance by integrating DNA microarrays and genetic mapping. Anim Genet 32:: 351--359.
16. Yonash N, Bacon LD, Witter RL, Cheng HH, ((1999)) High resolution mapping and identification of new quantitative trait loci (QTL) affecting susceptibility to Marek's disease. Anim Genet 30:: 126--135.
17. Vallejo R, Liu H, Cheng H, Witter R, Bacon L, et al. ((1997)) Non association between Rfp Y major histocompatibility complex like genes and susceptibility to Marek's disease virus induced tumours in 63×72 F2 intercross chickens. Animal genetics 28:: 331--337.
18. Esteller M, ((2008)) Epigenetics in cancer. N Engl J Med 358:: 1148--1159.
19. Sharma S, Kelly TK, Jones PA, ((2010)) Epigenetics in cancer. Carcinogenesis 31:: 27--36.
20. Esteller M, ((2007)) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8:: 286--298.
21. Yu Y, Zhang H, Tian F, Zhang W, Fang H, et al. ((2008)) An integrated epigenetic and genetic analysis of DNA methyltransferase genes (DNMTs) in tumor resistant and susceptible chicken lines. PLoS One 3:: e2672.
22. Yu Y, Zhang H, Tian F, Bacon L, Zhang Y, et al. ((2008)) Quantitative evaluation of DNA methylation patterns for ALVE and TVB genes in a neoplastic disease susceptible and resistant chicken model. PLoS One 3:: e1731.
23. Luo J, Yu Y, Zhang H, Tian F, Chang S, et al. ((2011)) Down-regulation of promoter methylation level of CD4 gene after MDV infection in MD-susceptible chicken line. BMC Proc 5 (Suppl 4):: S7.
24. Kouzarides T, ((2007)) Chromatin modifications and their function. Cell 128:: 693--705.
25. Ha M, Ng DW, Li WH, Chen ZJ, ((2011)) Coordinated histone modifications are associated with gene expression variation within and between species. Genome Res 21:: 590--598.
26. Zhang X, Clarenz O, Cokus S, Bernatavichute YV, Pellegrini M, et al. ((2007)) Whole-genome analysis of histone H3 lysine 27 trimethylation in Arabidopsis. PLoS Biol 5:: e129.
27. Pokholok DK, Harbison CT, Levine S, Cole M, Hannett NM, et al. ((2005)) Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122:: 517--527.
28. Li T, Kelly WG, ((2011)) A role for Set1/MLL-related components in epigenetic regulation of the Caenorhabditis elegans germ line. PLoS Genet 7:: e1001349.
29. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, et al. ((2007)) High-resolution profiling of histone methylations in the human genome. Cell 129:: 823--837.
30. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, et al. ((2008)) Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40:: 897--903.
31. Wei G, Wei L, Zhu J, Zang C, Hu-Li J, et al. ((2009)) Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30:: 155--167.
32. Araki Y, Wang Z, Zang C, Wood WH 3rd, Schones D, et al. ((2009)) Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells. Immunity 30:: 912--925.
33. Vastenhouw NL, Zhang Y, Woods IG, Imam F, Regev A, et al. ((2010)) Chromatin signature of embryonic pluripotency is established during genome activation. Nature 464:: 922--926.
34. Roh TY, Cuddapah S, Zhao K, ((2005)) Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes & development 19:: 542.
35. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, et al. ((2008)) Combinatorial patterns of histone acetylations and methylations in the human genome. Nature genetics 40:: 897--903.
36. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, et al. ((2007)) High-resolution profiling of histone methylations in the human genome. Cell 129:: 823--837.
37. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA, ((2007)) A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130:: 77--88.
38. Wang Z, Schones DE, Zhao K, ((2009)) Characterization of human epigenomes. Current opinion in genetics & development 19:: 127--134.
39. Seligson DB, Horvath S, Shi T, Yu H, Tze S, et al. ((2005)) Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435:: 1262--1266.
40. Wei Y, Xia W, Zhang Z, Liu J, Wang H, et al. ((2008)) Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog 47:: 701--706.
41. Park YS, Jin MY, Kim YJ, Yook JH, Kim BS, et al. ((2008)) The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma. Ann Surg Oncol 15:: 1968--1976.
42. Varier RA, Timmers HT, ((2011)) Histone lysine methylation and demethylation pathways in cancer. Biochim Biophys Acta 1815:: 75--89.
43. Yu Y, Luo J, Mitra A, Chang S, Tian F, et al. ((2011)) Temporal transcriptome changes induced by MDV in Marek's disease-resistant and-susceptible inbred chickens. BMC Genomics 12:: 501.
44. Tian F, Luo J, Zhang H, Chang S, Song J, ((2012)) MiRNA expression signatures induced by Marek's disease virus infection in chickens. Genomics 99:: 152--159.
45. Burgess SC, Basaran BH, Davison TF, ((2001)) Resistance to Marek's disease herpesvirus-induced lymphoma is multiphasic and dependent on host genotype. Vet Pathol 38:: 129--142.
46. Burgess SC, Davison TF, ((2002)) Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37. J Virol 76:: 7276--7292.
47. Schat KA, ((1981)) Role of the spleen in the pathogenesis of Marek's disease. Avian Pathol 10:: 171--182.
48. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, et al. ((2008)) Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134:: 521--533.
49. Barski A, Jothi R, Cuddapah S, Cui K, Roh TY, et al. ((2009)) Chromatin poises miRNA- and protein-coding genes for expression. Genome Res 19:: 1742--1751.
50. Zhang Z, Zhang MQ, ((2011)) Histone modification profiles are predictive for tissue/cell-type specific expression of both protein-coding and microRNA genes. BMC Bioinformatics 12:: 155.
51. Cui K, Zang C, Roh TY, Schones DE, Childs RW, et al. ((2009)) Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 4:: 80--93.
52. van Dijk K, Ding Y, Malkaram S, Riethoven JJ, Liu R, et al. ((2010)) Dynamic changes in genome-wide histone H3 lysine 4 methylation patterns in response to dehydration stress in Arabidopsis thaliana. BMC Plant Biol 10:: 238.
53. Greer EL, Shi Y (2012) Histone methylation: a dynamic mark in health, disease and inheritance. Nature Reviews Genetics Published online.
54. Anderton JA, Bose S, Vockerodt M, Vrzalikova K, Wei W, et al. ((2011)) The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's Lymphoma. Oncogene 30:: 2037--2043.
55. Ha M, Ng D, Li WH, Chen ZJ, ((2011)) Coordinated histone modifications are associated with gene expression variation within and between species. Genome Res.
56. Li X, Wang X, He K, Ma Y, Su N, et al. ((2008)) High-resolution mapping of epigenetic modifications of the rice genome uncovers interplay between DNA methylation, histone methylation, and gene expression. Plant Cell 20:: 259--276.
57. Yu Y, Luo J, Mitra A, Chang S, Tian F, et al. ((2011)) Temporal Transcriptome Changes Induced by MDV in Marek's Disease-Resistant and-Susceptible Inbred Chickens. BMC Genomics 12:: 501.
58. Heidari M, Sarson AJ, Huebner M, Sharif S, Kireev D, et al. ((2010)) Marek's disease virus-induced immunosuppression: array analysis of chicken immune response gene expression profiling. Viral Immunol 23:: 309--319.
59. Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, et al. ((2001)) Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 194:: 847--853.
60. Hoshino A, Kawamura YI, Yasuhara M, Toyama-Sorimachi N, Yamamoto K, et al. ((2007)) Inhibition of CCL1-CCR8 interaction prevents aggregation of macrophages and development of peritoneal adhesions. J Immunol 178:: 5296--5304.
61. O'Neill LA, Fitzgerald KA, Bowie AG, ((2003)) The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol 24:: 286--290.
62. Carty M, Goodbody R, Schroder M, Stack J, Moynagh PN, et al. ((2006)) The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol 7:: 1074--1081.
63. Szretter KJ, Samuel MA, Gilfillan S, Fuchs A, Colonna M, et al. ((2009)) The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile Virus pathogenesis. J Virol 83:: 9329--9338.
64. Hanahan D, Weinberg RA, ((2011)) Hallmarks of cancer: the next generation. Cell 144:: 646--674.
65. He L, Hannon GJ, ((2004)) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:: 522--531.
66. Chen K, Rajewsky N, ((2007)) The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 8:: 93--103.
67. Calin GA, Croce CM, ((2006)) MicroRNA signatures in human cancers. Nat Rev Cancer 6:: 857--866.
68. Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, et al. ((2008)) Chromatin structure analyses identify miRNA promoters. Genes Dev 22:: 3172--3183.
69. Nichols DE, Nichols CD, ((2008)) Serotonin receptors. Chem Rev 108:: 1614--1641.
70. Kobilka BK, ((2011)) Structural insights into adrenergic receptor function and pharmacology. Trends Pharmacol Sci 32:: 213--218.
71. Schorr EC, Arnason BG, ((1999)) Interactions between the sympathetic nervous system and the immune system. Brain Behav Immun 13:: 271--278.
72. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES, ((2000)) The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52:: 595--638.
73. Bergquist J, Tarkowski A, Ewing A, Ekman R, ((1998)) Catecholaminergic suppression of immunocompetent cells. Immunol Today 19:: 562--567.
74. Morimura T, Hattori M, Ohashi K, Sugimoto C, Onuma M, ((1995)) Immunomodulation of peripheral T cells in chickens infected with Marek's disease virus: involvement in immunosuppression. J Gen Virol 76 (Pt 12) (): 2979--2985.
75. Forstermann U, Kleinert H, ((1995)) Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch Pharmacol 352:: 351--364.
76. Xing Z, Schat KA, ((2000)) Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus. J Virol 74:: 3605--3612.
77. Xing Z, Schat KA, ((2000)) Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures. Immunology 100:: 70--76.
78. Michel T, Vanhoutte PM, ((2010)) Cellular signaling and NO production. Pflugers Arch 459:: 807--816.
79. Papageorgiou A, Denef C, ((2007)) Stimulation of growth hormone release by 5-hydroxytryptamine (5-HT) in cultured rat anterior pituitary cell aggregates: evidence for mediation by 5-HT2B, 5-HT7, 5-HT1B, and ketanserin-sensitive receptors. Endocrinology 148:: 4509--4522.
80. Buonomo FC, Zimmermann NG, Lauterio TJ, Scanes CG, ((1984)) Catecholamine involvement in the control of growth hormone secretion in the domestic fowl. Gen Comp Endocrinol 54:: 360--371.
81. Liu HC, Kung HJ, Fulton JE, Morgan RW, Cheng HH, ((2001)) Growth hormone interacts with the Marek's disease virus SORF2 protein and is associated with disease resistance in chicken. Proc Natl Acad Sci U S A 98:: 9203--9208.
82. Li X, Chiang HI, Zhu J, Dowd SE, Zhou H, ((2008)) Characterization of a newly developed chicken 44K Agilent microarray. BMC Genomics 9:: 60.
83. Zang C, Schones DE, Zeng C, Cui K, Zhao K, et al. ((2009)) A clustering approach for identification of enriched domains from histone modification ChIP-Seq data. Bioinformatics 25:: 1952--1958.